1-16023055-G-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_004070.4(CLCNKA):​c.100+336G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0214 in 152,368 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.021 ( 59 hom., cov: 34)

Consequence

CLCNKA
NM_004070.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.325

Publications

1 publications found
Variant links:
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CLCNKA Gene-Disease associations (from GenCC):
  • Bartter disease type 4B
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-16023055-G-T is Benign according to our data. Variant chr1-16023055-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 1316530.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0214 (3260/152368) while in subpopulation NFE AF = 0.0284 (1933/68028). AF 95% confidence interval is 0.0274. There are 59 homozygotes in GnomAd4. There are 1630 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 59 Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKANM_004070.4 linkc.100+336G>T intron_variant Intron 2 of 19 ENST00000331433.5 NP_004061.3 P51800-1
CLCNKANM_001042704.2 linkc.100+336G>T intron_variant Intron 2 of 19 NP_001036169.1 P51800-3
CLCNKANM_001257139.2 linkc.100+336G>T intron_variant Intron 2 of 18 NP_001244068.1 P51800-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKAENST00000331433.5 linkc.100+336G>T intron_variant Intron 2 of 19 1 NM_004070.4 ENSP00000332771.4 P51800-1

Frequencies

GnomAD3 genomes
AF:
0.0214
AC:
3259
AN:
152250
Hom.:
59
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00506
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.0169
Gnomad ASJ
AF:
0.0619
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0176
Gnomad FIN
AF:
0.0368
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0284
Gnomad OTH
AF:
0.0235
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0214
AC:
3260
AN:
152368
Hom.:
59
Cov.:
34
AF XY:
0.0219
AC XY:
1630
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00507
AC:
211
AN:
41590
American (AMR)
AF:
0.0167
AC:
256
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0619
AC:
215
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.0178
AC:
86
AN:
4832
European-Finnish (FIN)
AF:
0.0368
AC:
391
AN:
10628
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0284
AC:
1933
AN:
68028
Other (OTH)
AF:
0.0232
AC:
49
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
161
323
484
646
807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0130
Hom.:
3
Bravo
AF:
0.0195
Asia WGS
AF:
0.00779
AC:
27
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.0
DANN
Benign
0.51
PhyloP100
-0.33
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111470804; hg19: chr1-16349550; API